Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)
(PAR-21-247)
National Human Genome Research Institute
National Cancer Institute
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s):
October 1, 2021; June 15, 2022; June 15, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
(RFA-HL-22-014)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s):
October 08, 2021
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
(RFA-MH-21-205)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s):
Multiple dates, see announcement.